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Abstract. Genetically-modified mice are widely applied in 
cardiovascular studies as model organisms. Echocardiography 
is a key tool for evaluating cardiac and hemodynamic func-
tions in mice. The present study aimed to examine the effects 
of isoflurane (ISF) on conventional and speckle tracking 
echocardiography (STE) parameters under healthy and 
pathological conditions using a murine model of pressure 
overload. In addition, the optimal dose of ISF in the process 
of echocardiographic measurement, with minimum cardiac 
contraction depression, was investigated. Conventional 
echocardiographic and STE examinations were performed 
on 38 adult C57BL/6 male mice. The mice were divided into 
the following three groups: The sham (n=15); mild thoracic 
aortic banding (TAB; n=15); and severe TAB (n=8) groups. 
ISF was administered under deep anesthesia (DA; 1-2% ISF), 
light anesthesia (LA; 0.5-1% ISF) and immediately prior to 
the mice waking up (awake; 0-0.5% ISF). Conventional echo-
cardiographic parameters were preserved within the sham 
and mild TAB groups (P>0.05 for each parameter) under LA 
and awake conditions. However, under DA conditions, the 
majority of these parameters were reduced compared with 
the LA and awake conditions (P<0.05). In the severe TAB 
group, conventional echocardiographic parameters remained 
constant under LA, DA and awake conditions. STE param-
eters in the groups remained similar between the LA and 
awake conditions, but were significantly reduced under DA 
conditions. Therefore, conventional echocardiography and 
STE may be performed using LA induced with low doses of 
ISF, under various pathological conditions without affecting 
cardiac function.
Introduction
Advancements in transgenic technology have resulted 
in genetically-modified mice being widely employed as 
model organisms in mechanistic studies of cardiovascular 
disease (1,2). The development of accurate and non-invasive 
techniques for the quantitative and phenotypic characteriza-
tion of cardiac function in healthy myocardium is crucial for 
obtaining the full benefits of these models. Echocardiography 
is an effective approach for quantitatively and accurately 
evaluating cardiac function and morphology (3,4). Despite 
these advantages, conventional echocardiography, such as 
M-mode assessment, is offset by the poor sensitivity for 
detecting subtle cardiac dysfunction (5). Therefore, there 
is a constant and pressing requirement for novel echocar-
diography techniques to enhance the assessment of cardiac 
function. The deformation (strain) imaging is one of these 
advanced techniques, which enables the improved quantifi-
cation of global and regional cardiac function. It captures 
segmental displacement and velocity of the left ventricle in 
multiple planes over the cardiac circle and can be acquired 
from tissue Doppler or 2-dimensional speckle tracking 
echocardiography (STE) (6). In the STE method, the 
speckles resulting from acoustic interference phenomena 
are used to track the movement of myocardium (7). Due to 
the benefits of high reproducibility and angle‑independency 
over color tissue Doppler imagining, STE has been widely 
applied (8). Prior studies have demonstrated that anesthetic 
agents may serve a significant function in the evaluation of 
echocardiographic parameters in mice (9). Isoflurane (ISF) 
is a volatile anesthetic that has been identified as a potential 
anesthetic agent for use in experimental studies involving 
mice, as it facilitates rapid conduction and easy control of 
the depth of anesthesia during conventional echocardiog-
raphy (10-13).
Effects of anesthesia on conventional and speckle 
tracking echocardiographic parameters in a 
mouse model of pressure overload
GUAN WANG1,  LE ZHANG1,  ANNE MANYANDE2,  MING CAO1,  WEI HE1,  
XIAOFEN WU1,  JINLI WANG1  and  CUNTAI ZHANG1
1Department of Gerontology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 
 Wuhan, Hubei 430030, P.R. China; 2School of Psychology, Social Work and Human Sciences, 
 University of West London, London W5 5RF, UK
Received September 12, 2014;  Accepted February 11, 2015
DOI: 10.3892/etm.2015.2331
Correspondence to: Professor Cuntai Zhang, Department of 
Gerontology, Tongji Hospital, Tongji Medical College, Huazhong 
University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 
Hubei 430030, P.R. China
E-mail: ctzhang2000@gmail.com
Key words: mouse, heart failure, hypertrophy, echocardiography, 
left ventricular function
WANG et al:  EFFECT OF ANESTHESIA ON ECHOCARDIOGRAPHIC PARAMETERS IN MICE1680
Due to the novelty of the STE technique, few studies have 
examined the effects of anesthesia on the parameters of STE. 
Previous studies have focused primarily on investigating the 
effects of anesthesia on the echocardiographic analysis of 
healthy subjects (9,14). As a result, the effects of anesthesia 
on cardiac function under pathological conditions remain 
unknown.
Therefore, the present study aimed to investigate the 
effects of an anesthetic agent on STE parameters in mice with 
hypertrophic and failing myocardium, in addition to healthy 
mice. Furthermore, the effects of anesthesia on conventional 
echocardiographic parameters were assessed in mice with 
healthy, hypertrophic and failing myocardium.
Materials and methods
Animals. The current study was approved by the Institutional 
Animal Care and Use Committee of Tongji Hospital, Huazhong 
University of Science and Technology (Wuhan, China). Adult 
C57BL/6 male mice (age, 8-10 weeks; weight, 20-24 g) were 
acquired from the Wuhan University Centre for Animal 
Experiments (Wuhan, China). Mice were maintained in an 
air-conditioned environment with a 12 h alternating light 
and dark cycle and received a standard rodent diet and water 
ad libitum.
Experimental protocol. In total, 45 mice were divided at random 
into the sham (n=15), mild thoracic aortic banding (TAB; n=15) 
and severe TAB (n=15) groups. The mice were anesthetized 
with ketamine (100 mg/kg; Jiangsu Hengrui Medicine Co., 
Ltd., Lianyungang, China) and xylazine (5 mg/kg; Lloyd Inc., 
Shenandoah, IA, USA), administered intraperitoneally. A 3-mm 
left-sided thoracotomy was made at the second intercostal 
space. The transverse aortic arch was exposed and ligated 
(7-0 Prolene suture; Shanghai Medical Suture Needle Factory, 
Shanghai, China) using a 25 or 27G needle, between the right 
innominate and left common carotid arteries, to induce the mild 
and severe TAB, respectively. The needle was then removed 
rapidly, leaving a discrete region of stenosis. The chest incision 
was subsequently closed and the left-side pneumothorax was 
evacuated. The sham group underwent an identical procedure, 
but without the ligation of the aortic arch. At week 8, each 
group was examined using conventional echocardiography 
and STE. During the echocardiographic examinations, varying 
doses of ISF (Lunan Pharmaceutical Group Corporation, 
Shandong, China) were administered, and heart rate (HR) was 
used to determine the depth of the anesthesia. The three states 
of anesthesia that were induced in the mice were as follows: 
Awake (0-0.5% ISF administered immediately prior to the mice 
waking up; HR, >520 bpm); light anesthesia (LA; ISF, 0.5-1%; 
HR, 460-520 bpm); and deep anesthesia (DA; ISF, 1-2%; HR, 
390-460 bpm).
Anesthesia and preparation of echocardiography. The mice 
were anesthetized by ISF inhalation, which was administered via 
a Vevo Compact Dual Anesthesia System (VisualSonics, Inc., 
Toronto, ON, Canada). Anesthesia induction was performed for 
3 min with 2% ISF/98% O2. Following the failure of the righting 
reflex, the mice were placed on a heating pad in the supine posi-
tion in order to maintain normothermia. The dose of ISF was 
altered as echocardiography was performed under awake, LA 
and DA conditions. Under each condition, the concentration of 
ISF was adjusted to maintain the immobility and sedation of 
the mice. Anesthetic was administered via a nose cone at a flow 
rate of 1-1.5 l/min. To produce an electrocardiogram (ECG), 
copper electrodes on the heating pad were covered with ECG 
gel (Parker Laboratories, Inc., Fairfield, NJ, USA). The paws of 
the mice were taped to the electrodes and the ECG was recorded 
simultaneously. The walls of the chest were shaved and ultra-
sound gel (Parker Laboratories, Inc.) was applied liberally to the 
thoracic region to optimize the visibility of the left ventricular 
(LV) chamber and the wall motion.
Conventional echocardiography and parameters. Conventional 
echocardiography was performed using a high-resolution 
Vevo 2100 System with a 30 MHz MS400 linear array trans-
ducer (VisualSonics, Inc.). B-Mode and M-mode images were 
obtained in short axis view at the papillary level and in para-
sternal long-axis view, with the aortic arch and endocardium in 
optimal view. The image depth, width and gain settings were 
adjusted during the data acquisition period. The frame rate 
remained at >200 Hz in all B-mode and M-mode images in 
order to optimize image quality.
M-mode tracings were used to digitally measure the 
LV end-diastolic diameter (LVEDD), LV end-systolic 
diameter (LVESD) and HR. Based on these measurements, 
the LV end-systolic volume (LVESV) was calculated as 
[7.0/(2.4 + LVESD)] x LVESD. The LV end-diastolic volume 
(LVEDV) was calculated as [7.0/(2.4 + LVEDD)] x LVEDD. 
The eject ion f ract ion (EF)  was ca lcu lated as 
[(LVEDV-LVESV)/LVEDV] x 100%. The fraction shortening 
(FS) was calculated as [(LVEDD-LVESD)/LVEDD] x 100%. 
The stroke volume (SV) was calculated as LVEDV-LVESV. 
The LV mass was calculated as 1.053 x [(LVEDD + LVPWTd 
+ LVAWTd)3-LVEDD3], in which LVPWTd denotes LV poste-
rior wall thickness in diastole and LVAWTd denotes LV anterior 
wall thickness in diastole. The corrected LV mass was the LV 
mass x 0.8. All measurements were presented as the mean of 
three adjacent cardiac cycles.
Strain analysis. Myocardium strain analyses were performed 
using VevoStrain software, version 1.4.0 (VisualSonics, Inc.). 
Images that presented the clearest visualization of the endo-
cardium and epicardium border with the fewest artifacts were 
selected. All the analyses were conducted by the same trained 
operator who was blinded to the groups. Tracking points 
were placed in three consecutive cardiac circles. The endo-
cardium and epicardium were then traced semi-automatically 
(Fig. 1A and B). The tracking points were adjusted manually 
to achieve well-defined tracking. Images were analyzed 
frame-by-frame using the VevoStrain software. The left 
ventricles were divided into six segments. For the parasternal 
long-axis view, they were divided as follows: Posterior apex, 
posterior base, posterior medium, anterior base, anterior medium 
and anterior apex (Fig. 1A and C). For the short axis view, they 
were divided into anterior free wall, lateral wall, posterior wall, 
inferior free wall, posterior septum wall and anterior septum 
wall. Strain values and the corresponding strain-rate curves 
were acquired for each segment in longitudinal (Fig. 1C), radial 
(Fig. 1D) and circumferential planes (Fig. 1E). The strain and 
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strain-rate of each segment were averaged in order to analyze 
global function.
Intra‑ and inter‑observer variability. To assess the 
intra-observer variability, nine data sets from each group were 
selected at random and re-analyzed by the original investigator 
following an interval of several weeks. Inter-observer vari-
ability was assessed by comparing the results of two observers 
repeatedly analyzing the same data sets. Data were evaluated 
as the difference between the two observations divided by the 
mean and expressed as the percentage and the correlation coef-
ficient (15,16).
Statistical analysis. Data are expressed as the mean ± standard 
error. The differences between the awake, LA and DA condi-
tions were calculated using one-way analysis of variance, while 
Bonferroni post hoc analysis was used for multiple compari-
sons. P<0.05 was considered to indicate a statistically significant 
difference. All analyses were performed using SPSS software, 
version 17.0 (SPSS, Inc., Chicago, IL, USA).
Results
Classic hypertrophic responses were observed in mice in the 
mild TAB group. The response included the preservation of 
EF and FS during the hypertrophic stage and a significant 
Figure 1. Representative images of the STE analysis. Endocardium and epicardium were semi-automated and traced by the analyzing software in parasternal 
(A) long axis view and (B) short axis view. (C) Longitudinal and (D) radial strain value in each segment (including posterior base, mid posterior, posterior apex, 
anterior base, mid anterior and anterior apex) of left ventricle. (E) Circumferential strain curves for each segment (including anterior free wall, lateral wall, 
posterior wall, inferior free wall, posterior septum wall and anterior septum wall) of left ventricle. STE, speckle tracking echocardiogram.
Figure 2. Typical short axis M-mode images of left ventricle in each group. 
Examples of short axis M-mode images from the (A) sham, (B) mild TAB 
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increase in the LV wall thickness and mass compared with 
the sham group (Table I). The STE parameters, including 
longitudinal strain (LS), radial strain (RS) and corre-
sponding strain rate exhibited a small reduction compared 
with the sham group. The circumferential strain (CS) and 
strain rate were preserved in the mild TAB group compared 
with the sham group (Table I), which may be attributed to 
the compensation mechanism (15). Furthermore, the severe 
TAB group mice exhibited a trend towards heart failure 
(HF) following TAB (Table I). In addition, severe TAB 
mice manifested typical clinical features of HF syndrome, 
including lethargy, impaired mobility and edema. During 
the post-banding period, 4/15 severe TAB mice succumbed, 
possibly to acute decompensated HF and arrhythmia. Three 
mice were excluded from the severe TAB group due to brady-
cardia. Conventional echocardiography indicated that EF 
and FS were significantly reduced in the severe TAB group 
(Table I). The STE parameters, including LS, RS, CS and 
corresponding strain rate were significantly reduced in the 
severe TAB group compared with the sham and mild TAB 
groups, whilst an increase was observed in the LVEDV and 
LVESV values (Table I). Fig. 2 exhibits marked differences 
in cardiac contraction and LV wall chamber cavity sizes 
among the sham, mild TAB and severe TAB groups.
Effects of anesthesia on conventional echocardiography. To 
assess the effect of anesthesia on conventional echocardiographic 
parameters, the values for these parameters in the awake, LA and 
DA conditions were compared among the sham (Table II), mild 
TAB (Table III) and severe TAB groups (Table IV). In all three 
groups the stepwise increase of ISF dose appeared to gradually 
reduce HR under the awake, LA and DA conditions (P<0.05). 
The conventional echocardiographic parameters examined 
included LVEDD, LVESD, LVPWTd, LVPWTs (LV posterior 
wall thickness in systole), LVAWTd, LVAWTs (LV anterior 
wall thickness in systole), LVEDV, LVESV, EF, FS, LV mass, 
corrected LV mass and SV. All of these parameters remained 
stable under the LA and awake conditions in the sham and mild 
TAB groups (P>0.05; Tables II and III). However, an increase in 
ISF concentration resulted in a significant suppression of these 
conventional parameters under the DA condition compared 
with the awake and LA conditions (P<0.05; Tables II and III). 
However, there were exceptions, including the LV and corrected 
LV mass in the sham and mild TAB groups, which did not change 
with the different ISF conditions. Furthermore, no reduction was 
observed in the LVPWTd parameter in the sham group under 
DA conditions. Analysis of the severe TAB group indicated that 
all the conventional echocardiographic parameters remained 
constant under awake, LA and DA conditions (Table IV).
Table I. Postoperative changes in echocardiographic parameters following TAB.
Parameter Sham Mild TAB Severe TAB
Conventional measures
  Body weight (g) 23.27±0.74 27.06±0.35 25.44±0.79
  HR (bpm) 520±7ab 512±6a 477±9
  LVEDD (mm) 3.6±0.09a 3.67±0.17a 4.31±0.44
  LVESD (mm) 2.09±0.09a 2.05±0.23a 3.14±0.60
  LVWT (mm) 1.13±0.02b 1.46±0.03a 1.17±0.06
  LVEDV (µl) 55.23±2.87a 60.96±6.60a 100.57±21.88
  LVESV (µl) 15.10±1.35a 22.71±6.79a 70.72±23.05
  EF (%) 76.15±2.71a 73.74±4.02a 46.18±4.79
  FS (%) 46.75±2.47a 41.36±3.61a 22.10±3.92
  LV mass (mg) 105.52±5.59ab 159.04±11.30a 198.88±12.87
  Corrected LV mass (mg) 84.41±4.47ab 133.27±10.21a 161.10±10.30
  SV (µl) 40.13±2.08a 42.06±2.67a 29.85±6.25
Strain measures   
Short axis   
  CS (%) -28.91±0.51a -29.15±1.44a -12.87±0.78
  CSR (s-1) -10.46±0.45a -10.68±0.8a -4.74±0.06
Long axis   
  LS (%) -26.83±1.8ab -20.01±1.43a -15.4±0.94
  LSR (s-1) -10.99±0.34ab -7.8±0.41a -5.7±0.21
  RS (%) 34.22±1.01ab 26.77±0.12a 14.28±1.08
  RSR (s-1) 9.95±0.62ab 7.45±0.22a 4.58±0.32
Values are presented as the mean ± standard error. aP<0.05 vs. severe TAB and bP<0.05 vs. mild TAB. TAB, thoracic aortic banding; HR, heart 
rate; LVWT, left ventricular wall thickness; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; 
LVESV, left ventricular end-systolic volume; LVEDV, left ventricular end-diastolic volume; EF, ejection fraction; FS, fraction shortening; 
LV mass; left ventricular mass; SV, stroke volume; CS, circumferential strain; CSR, circumferential strain rate; LS, longitudinal strain; LSR, 
longitudinal strain rate; RS, radial strain; RSR, radial strain rate.
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Effects of anesthesia on STE. The strain and corresponding 
strain rates were acquired from mice under the awake, LA 
and DA states in order to determine the effect of anesthesia 
on the results of STE examination. No significant differences 
in LS, CS, RS or corresponding strain rates were observed 
between the LA and awake conditions in the three groups 
Table II. Conventional echocardiographic parameters in the sham group mice under different states of anesthesia.
Parameter Awake LA DA
Weight (g) 22.52±0.41 23.27±0.74 23.15±0.66
HR (bpm) 567±11ab 520±5a 407±10
LVEDD (mm) 3.51±0.07a 3.6±0.09a 4.01±0.10
LVESD (mm) 2.06±0.07a 2.09±0.09a 2.88±0.12
LVPWTd (mm) 0.82±0.02 0.81±0.03 0.77±0.028
LVPWTs (mm) 1.31±0.04a 1.40±0.06a 1.08±0.044
LVAWTd (mm) 0.80±0.03a 0.85±0.03a 0.69±0.04
LVAWTs (mm) 1.34±0.04a 1.35±0.04a 1.00±0.06
LVEDV (µl) 52.41±2.27a 55.23±2.87a 70.791±4.00
LVESV (µl) 14.79±1.18a 15.10±1.35a 40.32±3.23
EF (%) 72.53±1.52a 76.15±2.71a 54.34±2.55
FS (%) 41.29±1.30a 46.75±2.47a 28.09±1.60
LV mass (mg) 96.79±3.43 105.52±5.59 106.00±5.72
Corrected LV mass (mg) 77.44±2.75 84.41±4.47 84.81±4.58
SV (µl) 37.62±1.57a 40.13±2.08a 27.48±1.93
Values are presented as the mean ± standard error. aP<0.05 vs. DA and bP<0.05 vs. LA. LA, light anesthesia; DA, deep anesthesia; HR, heart 
rate; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; LVPWTd, left ventricular posterior wall 
thickness in diastole; LVPWTs, left ventricular posterior wall thickness in systole; LVAWTd, left ventricular anterior wall thickness in diastole; 
LVAWTs, left ventricular anterior wall thickness in systole; LVESV, left ventricular end-systolic volume; LVEDV, left ventricular end-diastolic 
volume; EF, ejection fraction; FS, fraction shortening; LV mass; left ventricular mass; SV, stroke volume.
Table III. Conventional echocardiographic parameters in the mild TAB group mice under different states of anesthesia.
Parameter Awake LA DA
Weight (g) 27.23±0.21 27.06±0.35 26.47±0.77
HR (bpm) 563±4ab 512±6a 395±8
LVEDD (mm) 3.53±0.10a 3.67±0.17a 4.44±0.08
LVESD (mm) 1.88±0.13a 2.05±0.23a 3.46±0.14
LVPWTd (mm) 1.13±0.04a 1.09±0.02a 0.93±0.04
LVPWTs (mm) 1.67±0.06a 1.59±0.09a 1.12±0.07
LVAWTd (mm) 1.24±0.05a 1.13±0.05a 0.94±0.05
LVAWTs (mm) 1.88±0.07a 1.74±0.08a 1.27±0.08
LVEDV (µl) 52.85±3.48a 60.96±6.60a 89.70±3.75
LVESV (µl) 12.33±2.23a 22.71±6.79a 51.29±4.82
EF (%) 78.88±2.53a 73.74±4.02a 44.45±3.49
FS (%) 47.96±2.29a 41.36±3.61a 22.47±2.19
LV mass (mg) 172.86±9.33 159.04±11.30 175.02±7.72
Corrected LV mass (mg) 138.37±7.47 133.27 ±10.21 140.04±6.18
SV (µl) 40.53±2.06a 42.06±2.6a 31.41±2.01
Values are presented as the mean ± standard error. aP<0.05 vs. DA and bP<0.05 vs. LA. TAB, thoracic aortic banding; LA, light anesthesia; DA, 
deep anesthesia; HR, heart rate; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; LVPWTd, left 
ventricular posterior wall thickness in diastole; LVPWTs, left ventricular posterior wall thickness in systole; LVAWTd, left ventricular anterior 
wall thickness in diastole; LVAWTs, left ventricular anterior wall thickness in systole; LVESV, left ventricular end-systolic volume; LVEDV, 
left ventricular end-diastolic volume; EF, ejection fraction; FS, fraction shortening; LV mass; left ventricular mass; SV, stroke volume.
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(P>0.05; Fig. 3). However, the STE parameters in all three 
groups exhibited significant differences under DA conditions 
compared with LA and awake conditions (P<0.05; Fig. 3).
Inter‑ and intra‑observer variability. The results of the 
analysis of inter- and intra-observer variability are presented 
in Table V. The data indicated no significant level of inter‑ and 
intra-observer variability and very high correlation coeffi-
cients for the conventional and STE parameters.
Discussion
The present study demonstrated that under LA conditions (HR 
range, 460-520 bpm; ISF range, 0.5-1%), conventional echocar-
diography and STE may be applied in healthy, hypertrophic 
and HF myocardium with a slight reduction of cardiac function.
Previous studies have reported that echocardiographic 
parameters are affected by anesthetic agents and that varying 
doses of anesthesia may influence the result of echocardio-
Table IV. Conventional echocardiographic parameters in the severe TAB group mice under different states of anesthesia.
Parameter Awake LA DA
Weight (g) 27.16±1.27 25.44±0.79 24.35±0.47
HR (bpm) 523±5ab 477±9a 404±8
LVEDD (mm) 4.54±0.47 4.31±0.44 4.95±0.28
LVESD (mm) 3.60±0.61 3.14±0.60 4.09±0.43
LVPWTd (mm) 0.99±0.12 0.96±0.11 0.84±0.04
LVPWTs (mm) 1.29±0.17 1.40±0.17 1.04±0.04
LVAWTd (mm) 1.16±0.06 1.13±0.06 1.02±0.05
LVAWTs (mm) 1.46±0.11 1.49±0.10 1.32±0.11
LVEDV (µl) 101.30±23.73 100.57±21.88 103.03±14.44
LVESV (µl) 75.66±23.74 70.72±23.05 75.16±18.14
EF (%) 47.03±11.23 46.18±4.79 46.84±7.93
FS (%) 26.42±8.36 22.10±3.92 28.44±4.37
LV mass (mg) 209.36±12.13 198.88±12.87 204.42±20.13
Corrected LV mass (mg) 167.48±9.71 161.10±10.30 163.53±16.11
SV (µl) 28.64±7.55 29.85±6.25 27.87±7.16
Values are presented as the mean ± standard error. aP<0.05 vs. DA and bP<0.05 vs. LA. TAB, thoracic aortic banding; LA, light anesthesia; DA, 
deep anesthesia; HR, heart rate; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; LVPWTs, left 
ventricular posterior wall thickness in systole; LVPWTd, left ventricular posterior wall thickness in diastole; LVAWTd, left ventricular anterior 
wall thickness in diastole; LVAWTs, left ventricular anterior wall thickness in systole; LVESV, left ventricular end-systolic volume; LVEDV, 
left ventricular end-diastolic volume; EF, ejection fraction; FS, fraction shortening; LV mass; left ventricular mass; SV, stroke volume.
Figure 3. Effect of anesthesia on STE parameters in the sham, mild TAB and severe TAB groups. Comparison of (A) longitudinal strain and (B) corresponding 
strain rate under awake, LA and DA conditions. Analysis of (C) radial strain and (D) corresponding strain rate under awake, LA and DA conditions. Evaluation 
of (E) circumferential strain and (F) corresponding strain rate under awake, LA and DA conditions. *P<0.05 vs. awake and #P<0.05 vs. LA. STE, speckle 
tracking echocardiogram; TAB, thoracic aortic banding; LA, light anesthesia; DA, deep anesthesia.
  A   C
  E
  B
  D   F
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graphic measurement (16-18). In the present study, a marked 
reduction was observed in the conventional echocardio-
graphic parameters of the sham group under DA conditions. 
However, these appeared to remain constant under awake 
and LA conditions. In agreement with this, conventional 
echocardiographic parameters were highly repeatable in the 
present study under LA conditions, despite a slight elevation 
in ISF dose and HR.
Anesthesia is considered to be an influential factor in the 
measurement of conventional echocardiographic parameters 
in healthy myocardium. However, a limited number of studies 
have investigated the effects of anesthesia on hypertrophic 
and failing myocardium. In the present study, conventional 
echocardiographic parameters in hypertrophic myocardium 
were reduced under DA conditions, but preserved under LA and 
awake conditions. However, the conventional echocardiographic 
parameters were unchanged in the failing myocardium under 
LA, DA and awake conditions. This may be attributable to the 
limited number of mice, which resulted in a large variability in 
conventional echocardiographic parameters in the severe TAB 
group compared with the sham and mild TAB groups.
The underlying mechanism for the improved reproducibility 
in mice under LA conditions may be attributed to the high HR 
in the LA and awake conditions. Generally, force-frequency 
dependence varied only minimally in high HR (>550 bpm) but 
altered significantly in the low HR conditions (<400 bpm) in 
murine hearts. Therefore, LV contractility remained almost 
unaltered under high HR conditions, which explained why 
echocardiographic parameters were constant under LA condi-
tions with high HR (18). The aforementioned data supports 
the hypothesis that conventional echocardiographic evaluation 
is clinically applicable under LA conditions in mice, with 
reduced cardiac systolic depression and perfect reproduc-
ibility. This protocol may be used in healthy or diseased mice.
The present study demonstrated that an increase of ISF 
dose and subsequent suppression of HR resulted in an evident 
reduction of the strain parameters in mice under DA condi-
tions, but no alteration in mice in the LA and awake states. 
However, a previous study by Weidemann et al (19) indicated 
that strain increased following a reduction in HR. This contra-
diction may be explained by the following mechanism: Strain 
is determined primarily by ejection performance parameters 
Table V. Intra- and inter-observer variability for conventional and speckle tracking echocardiography.
  Inter-observer Intra-observer
  ----------------------------------------------------------- ----------------------------------------------------------
Parameter % Error CC % Error CC
Conventional measures    
  LVEDD (mm) 0.7±1.3 0.84 0.5±0.2 0.86
  LVESD (mm) 3.3±2.6 0.98 2.4±1.7 0.99
  LVPWTd (mm) 9.6±2.5 0.89 4.3±1.8 0.94
  LVPWTs (mm) 3.8±2.6 0.95 4.5±1.4 0.92
  LVAWTd (mm) 4.9±1.1 0.89 3.7±1.3 0.9
  LVAWTs (mm) 2.6±3.1 0.97 1.7±3.5 0.98
  LVEDV (µl)  1.6±3.0 0.92 1.4±3.2 0.91
  LVESV (µl)  4.6±0.9 0.80 3.5±0.7 0.82
  EF (%) 6.2±1.5 0.82 4.9±0.5 0.87
  FS (%) 5.7±1.2 0.87 7.8±0.6 0.89
  LV mass (mg) 8.2±4.6 0.83 5.6±1.7 0.87
  Corrected LV mass (mg) 8.2±4.6 0.83 4.4±6.2 0.91
  SV (µl) 0.7±1.8 0.82 0.9±1.4 0.85
Strain measures    
Short axis    
  CS (%) 1.8±1.2 0.97 1.4±0.3 0.98
  CSR (s-1) 4.2±4.1 0.94 5.9±4.5 0.92
Long axis    
  LS (%) 1.9±1.6 0.92 1.8±2.1 0.90
  LSR (s-1) 3.8±3.0 0.93 4.5±4.0 0.96
  RS (%) 2.5±1.6 0.90 3.8±1.9 0.91
  RSR (s-1) 3.2±2.6 0.97 2.3±1.9 0.99
Values are presented as the mean ± standard error. LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diam-
eter; LVPWTd, left ventricular posterior wall thickness in diastole; LVPWTs, left ventricular posterior wall thickness in systole; LVAWTd, left 
ventricular anterior wall thickness in diastole; LVAWTs, left ventricular anterior wall thickness in systole; LVESV, left ventricular end-systolic 
volume; LVEDV, left ventricular end-diastolic volume; EF, ejection fraction; FS, fraction shortening; SV, stroke volume; CS, circumferential 
strain; LS, longitudinal strain; RS, radial strain; LSR, longitudinal strain rate; CSR, circumferential strain rate; RSR, radial strain rate.
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such as SV (20,21). Following a reduction in HR, the preload 
and ejection period increased, which led to an increase in 
SV and strain. However, under DA conditions, the increased 
administration of ISF reversed this trend by significantly 
reducing cardiac contraction (22,23). Due to the abnormal 
contraction observed in mice under DA conditions, the SV 
was considerably suppressed, which resulted in a reduction in 
strain.
In addition, the effect of anesthesia on strain rate was 
analyzed. Increasing the ISF dose and thus reducing HR 
resulted in a reduction in strain rate in mice under DA condi-
tions. However, strain rate remained constant in mice in the 
LA and awake states in each group. However, previous studies 
involving rats and dogs have indicated that strain rate is inde-
pendent of HR (14,24). This paradox may be explained by the 
following mechanism: With the reduction of HR, the intrinsic 
contractility reduced due to the negative Treppe effect (25). 
However, as the preload and ejection period increased, so 
did the intrinsic contractility, via the negative Frank-Starling 
mechanism (26). The combination of these two factors may 
have resulted in a balancing effect on the extent of contractility. 
Therefore, the strain rate as an index of change of contractility, 
remained the same as the HR fluctuated. However, as the dose 
of ISF increased under DA conditions, the contractility was 
suppressed significantly and the balancing effect on contrac-
tility was prevented. This may explain the significant reduction 
of strain rate under DA conditions.
There were a number of limitations to the present study: 
Firstly, conscious mice were not included as a control, as the 
elevation of sympathetic tone during conscious measurement 
could not be fully eliminated, despite the mice undergoing 
training a few days prior to the experiment (27). In addition, 
the images used for strain analysis must be of high resolution, 
with clear visualization of the endocardium and epicardium 
borders. Therefore, it is necessary that the mice be immobile, 
which would not have been feasible if the mice had remained 
conscious. Secondly, Doppler parameters were not measured 
due to the high HR, as Doppler waveforms merge together 
when there is a reduction in the diastolic period (28,29). Thirdly, 
bradycardic mice with a low HR (<500 bpm) and HF in the 
severe TAB group were excluded from the study. Therefore, the 
least healthy mice with HF were omitted from the study and the 
effects of anesthesia on HF mice may have been underestimated.
In conclusion, the present study conducted a novel 
investigation into the effects of anesthesia on conventional 
echocardiography and STE parameters in healthy mice and 
pathological models. The pathological model is of particular 
clinical relevance, as anesthesia may severely reduce cardiac 
contraction in patients with HF. In addition, the present study 
examined the effects of anesthesia in a mouse model of pressure 
overload/aortic stenosis and assessed whether an anesthetic 
was able to limit the effectiveness of echocardiography in 
the evaluation of cardiac function (30). Under LA conditions, 
relatively precise conventional and STE measurements may be 
obtained without a significant reduction in cardiac function. 
This approach offers a potentially valuable method for accu-
rately measuring conventional and STE parameters with good 
reproducibility. Thus, immobility and sedation may widen the 
applicability of conventional echocardiography and STE in 
healthy and diseased mice.
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